10:51 AM EST - Antibe Therapeutics Inc. : Announced a strategic collaboration with Dalriada Drug Discovery to develop new drug candidates and fortify Antibe’s intellectual property position for its current pipeline. Antibe Therapeutics Inc.
shares T.ATE are trading down $0.02 at $3.75.
